ECT-001-CB (UM171-Expanded Cord Blood Transplant) Clinical Trials

1 actively recruiting trial across 1 location

Also known as: Conditioning Regimen (Alternative): MIDI: fludarabine: 30 mg/m2/day IV x 5 days, cyclophosphamide: 50 mg/kg IV , thiotepa: 5 mg/kg/day IV x 2 days , TBI: 400 cGy, Conditioning Regimen (Preferred): clofarabine:30 mg/m2/day IV x 4 days, fludarabine:10 mg/m2/day IV x 4 days, busulfan: daily for 4 days with cumm Bu target = 90mg h/L, GVHD Prophylaxis: Tacrolimus/MMF